MARGINAL ZONE LYMPHOMA(MZL)

Clinical trials for MARGINAL ZONE LYMPHOMA(MZL) explained in plain language.

Never miss a new study

Get alerted when new MARGINAL ZONE LYMPHOMA(MZL) trials appear

Sign up with your email to follow new studies for MARGINAL ZONE LYMPHOMA(MZL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 2 Completed 1 Terminated 1

CAR-T therapy Follow-Up study shows no new safety surprises

Knowledge-focused Completed

This study followed 16 people with certain blood cancers who had already received a special treatment called CLBR001 CAR-T cells. The goal was to see if any new or long-term side effects appeared over time. Researchers also checked how well the cancer was controlled. The study di…

Matched conditions: MARGINAL ZONE LYMPHOMA(MZL)

Phase: PHASE1 • Sponsor: Calibr, a division of Scripps Research • Aim: Knowledge-focused

Last updated May 03, 2026 22:04 UTC

MARGINAL ZONE LYMPHOMA(MZL)

Get alerted when new MARGINAL ZONE LYMPHOMA(MZL) trials appear

CAR-T therapy Follow-Up study shows no new safety surprises